In patients with NSCLC, Sun et al. have reported that the combination of OPN and CD44v6 elevated expression of is a valuable independent predictor of tumor recurrence and survival in NSCLC patients [112]. The gene discussed is SPP1; the disease is non-small cell lung carcinoma.